KAZ954

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KAZ954, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors [EARLY_Phase 1]